Project cooperationUpdated on 22 December 2025
Modelling of Disease and Treatment
Manager, Medical-Computational Collaborations at Institute for Medical BioMathematics (IMBM)
Bene Ataroth, Israel
About
We at IMBM are interested in adding to clinical decision making by using mathematical modelling of diseases (infectious diseases, cancer, etc.) and treatment and based on these dynamic models generate prediction algorithms using machine learning methods. Mathematical modelling gives a scientific rational to the algorithm and allows to predict current drugs effects, but also new drugs.
We are looking to join a consortium in the areas of infectious disease modeling and treatment, modelling various cancer treatments, and clinical trial optimization by modelling patients under various treatments.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Modelling of Disease and Treatment
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Gil Katz
Manager, Medical-Computational Collaborations at Institute for Medical BioMathematics (IMBM)
Bene Ataroth, Israel
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Anastasiya Babintseva
Professor of the Department of Pediatrics, Neonatology and Perinatal Medicine at Bukovinian State Medical University
Chernivtsi, Ukraine
Project cooperation
AI-Driven Microfluidic 3D In Vitro Platform for Multi-Tissue Crosstalk in Drug Testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
MARCO BERZANO
Research Manager and Advisor - Head of Medical Area at Università Politecnica delle Marche
Ancona, Italy